Food Retail & Distribution

Page 1

Premier Foods plc sees FY 2014 trading profit towards the lower end of market expectations

2:01am EDT

Premier Foods plc:Expects FY 2014 trading profit to be towards the lower end of market expectations.

Tesco PLC declares interim dividend

2:01am EDT

Tesco PLC:Declares Interim dividend of 1.16 pence per share.Says it will be paid on Dec. 19 to shareholders who are on the Register of members at close of business on Oct. 31.

Diplomat Pharmacy Inc's Harvoni (ledipasvir/sofosbuvir) approved for the treatment of chronic hepatitis C, genotype 1 infection in adults

Wednesday, 22 Oct 2014 04:53pm EDT

Diplomat Pharmacy Inc:Says U.S. Food and Drug Administration (FDA) announced Oct. 10, that Gilead Sciences Harvoni (ledipasvir/sofosbuvir) product was approved for the treatment of chronic hepatitis C, genotype 1 infection in adults.Harvoni is the first oral combination therapy approved for the treatment of hepatitis C and is also the first treatment regimen that does not require administration with pegylated interferon or ribavirin.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Analyst Research

Report Title Price
Provider: Bohai Securities Co.,Ltd.
$92.00
Provider: Wright Reports
$75.00
Provider: Wright Reports
$35.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.